The Supreme Court is currently deliberating on a key provision of the Affordable Care Act that could have significant implications for preventive care coverage for millions of Americans. The case revolves around the constitutionality of Obamacare’s process for determining which services must be fully covered by private insurance.
In a hearing on Monday, conservative justices Brett Kavanaugh and Amy Coney Barrett appeared skeptical of arguments claiming that the process is unconstitutional. The case has the potential to impact preventive care coverage for approximately 150 million Americans, including vital medications and services such as statins for heart disease prevention, lung cancer screenings, HIV-prevention drugs, and breast cancer medication for high-risk women.
The plaintiffs in the case argue that the coverage requirements are unconstitutional because a volunteer board of medical experts recommended them without Senate approval. They have also raised religious and procedural objections. Despite President Donald Trump’s criticism of the law, the Trump administration defended the mandate before the court, asserting that board members do not require Senate approval as they can be removed by the health and human services secretary.
During the hearing, a majority of the justices appeared inclined to support the government’s position. Kavanaugh noted that there were no indications in the law suggesting that the board was intended to have the level of power that would necessitate Senate approval. Barrett also questioned the plaintiff’s interpretation of the board’s authority as “maximalist.”
A ruling on the case is expected by the end of June, with some justices considering the possibility of sending the case back to the U.S. 5th Circuit Court of Appeals. This could leave unanswered questions regarding which medications and services will remain covered under the law.
The case reached the Supreme Court after the appeals court struck down certain preventive care coverage requirements, siding with Christian employers and Texas residents who objected to providing full insurance coverage for services like HIV prevention and some cancer screenings. Represented by conservative attorney Jonathan Mitchell, the challengers argued that the coverage requirements were unconstitutional as they originated from a body whose members were not nominated by the president and confirmed by the Senate.
Despite the appeals court’s ruling, not all preventive care services were threatened. A 2023 analysis by the nonprofit KFF indicated that screenings such as mammography and cervical cancer screening would still be covered without out-of-pocket costs.
Overall, the Supreme Court’s decision on this case could have far-reaching consequences for preventive care coverage under the Affordable Care Act. It remains to be seen how the justices will rule and what impact it will have on the healthcare landscape in the United States.
